Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US association warns against Alzheimer's tests:

This article was originally published in Clinica

Executive Summary

The Los Angeles Alzheimer's Association has warned against the use of new tests to assist in the diagnosis of the disease. The note of caution coincides with the release of Athena Neurosciences' ADmark Assays (see page 22). "We don't yet know for certain how to interpret these tests, or how useful they will be in diagnosing Alzheimer's disease, " says Peter Braun, executive director of the association. He confirmed the Alzheimer Association's Ronald and Nancy Reagan Research Institute plans to assemble a panel of scientists to advise the medical community and the public on new diagnostic approaches to the disease.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087737

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel